3-乙基-2-庚醇,THREO+ERYTHRO | 19780-39-3

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: 3-乙基-2-庚醇,THREO+ERYTHRO
• 中文别名: 3-乙基-2-庚醇
• 英文名称: 3-Ethyl-2-heptanol
• 英文别名: 3-ethylheptan-2-ol
• CAS: 19780-39-3
• 化学式: C₉H₂₀O
• 分子量: 144.25
• InChiKey: MMQDVLWWGWJSFS-UHFFFAOYSA-N

物化性质

• 熔点：
  6.15°C (estimate)
• 沸点：
  192.9°C (estimate)
• 密度：
  0.8446 (estimate)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  10
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 危险类别码：
  R36/37/38
• 海关编码：
  2905199090
• 安全说明：
  S26,S36/37/39

文献信息

• Substituted melatonin derivatives, process for their preparation, and methods of use
  申请人：Tao Chunlin

  公开号：US20070191463A1

  公开（公告）日：2007-08-16

  The invention provides 2 aryl substituted derivatives of melatonin. The invention further provides pharmaceutical compositions comprising such derivatives, methods for preparing such derivatives, and methods of using such derivatives to induce general anesthesia, sedation, and/or hypnotic or sleep effects in a patient, and to treat conditions affected by melatonin activity in a patient.

  这项发明提供了2种芳基取代的褪黑激素衍生物。该发明还提供了包括这些衍生物的药物组合物，制备这些衍生物的方法，以及利用这些衍生物在患者中诱导全身麻醉、镇静和/或催眠或睡眠效果，并治疗受褪黑激素活性影响的患者病况的方法。
• [EN] PROCESS<br/>[FR] PROCÉDÉ
  申请人：PHOSPHAGENICS LTD

  公开号：WO2018112512A1

  公开（公告）日：2018-06-28

  An efficient and commercial phosphorylation process of a complex alcohol, such as secondary and tertiary alcohols, with P4O10 at high temperatures, and a product obtained by the process.

  一种高效商业化的磷酸酯化过程，用于复杂醇类（如二级和三级醇），在高温下使用P4O10，以及该过程得到的产品。
• 4,5- DIHYDROPYRAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY
  申请人：ABBVIE DEUTSCHLAND GMBH & CO. KG

  公开号：US20160075691A1

  公开（公告）日：2016-03-17

  The present invention relates to 4,5-dihydropyrazole derivatives of the formula (I) and physiologically tolerated salts thereof which are GlyT1 inhibitors. The invention further relates to pharmaceutical compositions comprising such 4,5-dihydropyrazole derivatives, and the use of such 4,5-dihydropyrazole derivatives for therapeutic purposes.

  本发明涉及式（I）的4,5-二氢吡唑衍生物及其生理耐受盐，其是GlyT1抑制剂。本发明还涉及包含这种4,5-二氢吡唑衍生物的药物组合物，以及使用这种4,5-二氢吡唑衍生物进行治疗目的的用途。
• Alkyl Tin Compound
  申请人：ASAHI KASEI CHEMICALS CORPORATION

  公开号：US20160228863A1

  公开（公告）日：2016-08-11

  An alkyl tin compound having an alkyl group bonded to a tin atom, wherein the alkyl group is a branched alkyl or cyclic group-substituted alkyl group, the branched alkyl group being an alkyl group branched at at least one carbon atom of the first to third carbon atoms counting from the tin atom, and the cyclic group-substituted alkyl group being an alkyl group having a cyclic group bonded at at least one carbon atom of the first to third carbon atoms counting from the tin atom.

  一种烷基锡化合物，其中烷基团与锡原子键合，其中烷基团是支链烷基或环基取代烷基团，所述支链烷基团是在从锡原子计数的第一至第三个碳原子中至少有一个碳原子分支的烷基团，所述环基取代烷基团是在从锡原子计数的第一至第三个碳原子中至少有一个碳原子与环基键合的烷基团。
• Radicicol derivatives, their preparation and their anti-tumour activity
  申请人：Sankyo Company Limited

  公开号：EP0460950A1

  公开（公告）日：1991-12-11

  Radiacol derivatives in which one or both hydroxy groups are acylated have valuable anti-tumor activity or may be used as chemical intermediates.

  其中一个或两个羟基被酰化的萝卜醇衍生物具有宝贵的抗肿瘤活性，或可用作化学中间体。